Beneficial effects of oral Premarin [conjugated estrogens] estrogen replacement therapy assessed by human genome array

Trial Profile

Beneficial effects of oral Premarin [conjugated estrogens] estrogen replacement therapy assessed by human genome array

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jul 2009

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Dyspareunia; Menopausal syndrome; Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 14 Jul 2009 Actual end date (Feb 2007) added as reported by ClinicalTrials.gov.
    • 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 May 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top